Repaglinide
- Product NDC
- 71335-2598
- 11-digit product format
- 713352598
- Labeler code
- 71335
- Product ID
- 71335-2598_b117a9ea-a66f-4642-8f50-0f7d8bcae492
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA207209
- Marketing category
- ANDA
- Marketing start
- 2023-03-22
- Substance
- REPAGLINIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 668Z8C33LU | REPAGLINIDE | 135062-02-1 | REPAGLINIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2598-1 | 71335259801 | 30 TABLET in 1 BOTTLE (71335-2598-1) | 30 tablet | 2025-06-05 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Repaglinide | Bryant Ranch Prepack | 2025-06-05 | HUMAN PRESCRIPTION DRUG LABEL | 1 |